Literature DB >> 22586797

Systemic treatment of adult atopic dermatitis.

Hannah Cookson1, Catherine Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22586797      PMCID： PMC4954107          DOI： 10.7861/clinmedicine.12-2-172

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  25 in total

Review 1.  Phototherapy for atopic dermatitis.

Authors:  J Krutmann
Journal:  Clin Exp Dermatol       Date:  2000-10       Impact factor: 3.470

2.  Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial.

Authors:  N J Reynolds; V Franklin; J C Gray; B L Diffey; P M Farr
Journal:  Lancet       Date:  2001-06-23       Impact factor: 79.321

3.  Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.

Authors:  J M Oldhoff; U Darsow; T Werfel; K Katzer; A Wulf; J Laifaoui; D J Hijnen; S Plötz; E F Knol; A Kapp; C A F M Bruijnzeel-Koomen; J Ring; M S de Bruin-Weller
Journal:  Allergy       Date:  2005-05       Impact factor: 13.146

4.  Treatment of atopic eczema with oral mycophenolate mofetil.

Authors:  K Neuber; I Schwartz; G Itschert; A T Dieck
Journal:  Br J Dermatol       Date:  2000-08       Impact factor: 9.302

5.  Treatment of recalcitrant atopic dermatitis with omalizumab.

Authors:  Joshua E Lane; Jason M Cheyney; Tanda N Lane; David E Kent; David J Cohen
Journal:  J Am Acad Dermatol       Date:  2005-11-28       Impact factor: 11.527

6.  Methotrexate for the treatment of adult atopic dermatitis.

Authors:  Catherine Goujon; Frédéric Bérard; Karima Dahel; Isabelle Guillot; Anca Hennino; Audrey Nosbaum; Nathalie Saad; Jean-François Nicolas
Journal:  Eur J Dermatol       Date:  2006 Mar-Apr       Impact factor: 3.328

7.  Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial.

Authors:  J Berth-Jones; A Takwale; E Tan; G Barclay; S Agarwal; I Ahmed; K Hotchkiss; R A C Graham-Brown
Journal:  Br J Dermatol       Date:  2002-08       Impact factor: 9.302

8.  Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.

Authors:  Simon J Meggitt; Janine C Gray; Nick J Reynolds
Journal:  Lancet       Date:  2006-03-11       Impact factor: 79.321

Review 9.  Systematic review of treatments for atopic eczema.

Authors:  C Hoare; A Li Wan Po; H Williams
Journal:  Health Technol Assess       Date:  2000       Impact factor: 4.014

10.  Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis.

Authors:  Colin N A Palmer; Alan D Irvine; Ana Terron-Kwiatkowski; Yiwei Zhao; Haihui Liao; Simon P Lee; David R Goudie; Aileen Sandilands; Linda E Campbell; Frances J D Smith; Gráinne M O'Regan; Rosemarie M Watson; Jo E Cecil; Sherri J Bale; John G Compton; John J DiGiovanna; Philip Fleckman; Sue Lewis-Jones; Gehan Arseculeratne; Ann Sergeant; Colin S Munro; Brahim El Houate; Ken McElreavey; Liselotte B Halkjaer; Hans Bisgaard; Somnath Mukhopadhyay; W H Irwin McLean
Journal:  Nat Genet       Date:  2006-03-19       Impact factor: 38.330
View more
  2 in total

Review 1.  New era of biologic therapeutics in atopic dermatitis.

Authors:  Emma Guttman-Yassky; Nikhil Dhingra; Donald Y M Leung
Journal:  Expert Opin Biol Ther       Date:  2013-01-16       Impact factor: 4.388

2.  Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis.

Authors:  April W Armstrong; Ahong Huang; Li Wang; Raymond Miao; Miraj Y Patel; Abhijit Gadkari; Usha G Mallya; Jingdong Chao
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.